The Trump Administration’s Blueprint: A Preview of the 23rd Annual MDRP Summit

Today’s guest post comes from Jean-Francois Denault, CEO and Owner of Impacts.CA. He discusses the Trump Administration’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. He outlines potential changes and their impact on pharmaceutical manufacturers. Knect365’s 23rd Annual Summit on the Medicaid Drug Rebate Program (MDRP) in Chicago will provide an opportunity to learn more about the administration’s drug pricing plans and such other topics as government pricing, rebates, and regulation. This event is notable for including many government officials along with over 500 industry participants. Register by July 27 to save up to $400 off the regular registration … Continue reading The Trump Administration’s Blueprint: A Preview of the 23rd Annual MDRP Summit

Specialty Pharmacy Management of Migraine Patients

Today’s guest post comes from Lily Duong, Chief Clinical Officer at Therigy. Lily discusses new migraine treatments that treat or prevent chronic and episodic migraine headaches. She highlights how these therapies will challenge specialty pharmacies. Therigy has developed a migraine therapy management solution to assist specialty pharmacies with patient management. To learn more, schedule a live demo of the TherigySTM™ migraine care plan. Read on for Lily’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          … Continue reading Specialty Pharmacy Management of Migraine Patients

Hidden Policies: The Search for Copay Accumulator Policies in Florida Qualified Health Plans

Today’s guest post comes from Carl Schmid, Deputy Executive Director of the AIDS Institute. The AIDS Institute studied health plans in Florida and uncovered a troubling reality: Patients are often unable to find out if their plan has a copay accumulator adjustment program. Even when the information was somehow available, it was vague and ambiguous. The AIDS Institute’s research shows how unsuspecting patients can get stuck with exorbitant out-of-pocket expenses for specialty drugs that have no generic or therapeutic alternatives. That’s why I told CNBC this week that accumulators are “as much of a cash grab from patients as I can possibly … Continue reading Hidden Policies: The Search for Copay Accumulator Policies in Florida Qualified Health Plans

The Pursuit of Excellence: Implementing an Integrated High Performing Specialty Pharmacy Model

Today’s guest post comes from Joseph Morse, CEO of Therigy. Joe describes challenges faced by specialty pharmacy leaders and Therigy’s solution for achieving a high performing, integrated specialty pharmacy service model. You can also download Therigy’s case study: Memorial Hermann Realizes Significant Care Enhancements and Cost Savings by Bringing Specialty Pharmacy Services In-House. This case study explores how the largest health system in southeast Texas developed internal specialty pharmacy services. Read on for Joe’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. and Copyright © 2006-2018 Drug Channels. This Feed is for personal non-commercial use only.          Powered … Continue reading The Pursuit of Excellence: Implementing an Integrated High Performing Specialty Pharmacy Model

Improving Patient Prescription Access and Adherence Journeys

Today’s guest post comes from Bill Nolan, VP/GM of McKesson Specialty Health. Bill discusses ExpressCoverage™, a solution from McKesson and CoverMyMeds®. It offers new ways for McKesson’s Patient Support Services to electronically access and efficiently communicate with a vast network of physicians, payers, and pharmacies. Bill highlights how this tool improves the specialty patient’s access and adherence to therapy. To learn more, download the free document ExpressCoverage™: Revolutionizing Patient Drug Access For Pharmaceutical Companies. Read on for Bill’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. and Copyright © 2006-2018 Drug Channels. This Feed is for personal non-commercial … Continue reading Improving Patient Prescription Access and Adherence Journeys

Copay Accumulator Programs: TrialCard Measures the Impact on Patients and Pharmaceutical Manufacturers

Today’s guest post comes from Mark Bouck, President and CEO of TrialCard. Mark reviews copay accumulator adjustment programs and shares some of TrialCard’s unique data about these programs. He also discusses TrialCard’s proprietary methodology for identifying patients affected by this benefit design. This topic is crucial for 2018 (per my own article from January), so I encourage you to review his commentary. To learn more about TrialCard’s approach to copay accumulator programs, download the free e-book The Rise of Co-Pay Accumulator Programs: Are Your Brand’s Patients at Risk? To learn more about TrialCard’s solutions for accumulators, email Mark Droke, TrialCard’s Senior … Continue reading Copay Accumulator Programs: TrialCard Measures the Impact on Patients and Pharmaceutical Manufacturers

The Role of Specialty Pharmacy in Population Health and Value-Based Care

Today’s guest post comes from Russel Allinson, Chief Executive Officer at Therigy. Russel describes the current shift from volume-based to value-based contracting for enhanced population health and patient care. He explains Geisinger’s innovative and successful Medication Therapy Disease Management Program. Russel highlights how TherigySTM enables the transition from volume-based to value-based contracting. The system’s new features help specialty pharmacies better manage care delivery, tracking, and reporting to stakeholders, while maintaining focus on the bottom line. Read on for Russ’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. and Copyright © 2006-2018 Drug Channels. This Feed is for personal … Continue reading The Role of Specialty Pharmacy in Population Health and Value-Based Care

Triplefin: How An Independent Service Provider Is Positioning for Growth

Today’s guest post comes from Tom Doyle, Executive Vice President Commercial Solutions at H. D. Smith / Triplefin. Tom shares his views on how an ndependent patient services provider can enhance a manufacturer’s internal efficiency and the patient experience. He discusses patient assistance programs, automation, integration, and customer engagement. To learn more about Triplefin’s full range of solutions, visit their booth at next week’s CBI Trade and Channel Strategies conference or visit www.triplefin.com. Read more » Copyright © 2006-2017 Pembroke Consulting, Inc. and Copyright © 2006-2017 Drug Channels. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Triplefin: How An Independent Service Provider Is Positioning for Growth

Drug Spending in 2017: The CEO of Prime Therapeutics Responds to Drug Channels

A few weeks ago, I highlighted the latest drug spending data in Reality Check: New Prime Therapeutics Data Show Very Low Drug Spending Growth in 2017. As I see it, these data contradict the public rhetoric about excessive growth in drug spending and prices. I concluded that drug spending is not actually “out of control.” Jim DuCharme, president and CEO of Prime Therapeutics, emailed me with an alternative and much more critical interpretation of the drug spending situation. Fortunately, he didn’t seem to mind my artistic choices. Jim was kind enough to allow me to share his thoughts with the … Continue reading Drug Spending in 2017: The CEO of Prime Therapeutics Responds to Drug Channels